Genomics

Dataset Information

MRTX1719 is an MTA-cooperative PRMT5 inhibitor that exhibits synthetic lethality in preclinical models and patients with MTAP deleted cancer


ABSTRACT: MRTX1719 is an MTA-cooperative PRMT5 inhibitor that exhibits synthetic lethality in preclinical models and patients with MTAP deleted cancer

PROVIDER: PRJNA1002360 | ENA |

REPOSITORIES: ENA